SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    DeGroot LJ, Kaplan EL, McCormick M, Straus FH. Natural history, treatment, and course of papillary thyroid carcinoma. J Clin Endocrinol Metab. 1990; 71: 414424.
  • 2
    van Heerden JA, Hay ID, Goellner JR, et al. Follicular thyroid carcinoma with capsular invasion alone: a nonthreatening malignancy. Surgery. 1992; 112: 11301138.
  • 3
    Shoup M, Stojadinovic A, Nissan A, et al. Prognostic indicators of outcomes in patients with distant metastases from differentiated thyroid carcinoma. J Am Coll Surg. 2003; 197: 191197.
  • 4
    Tickoo SK, Pittas AG, Adler M, et al. Bone metastases from thyroid carcinoma. A histopathologic study with clinical correlates. Arch Pathol Lab Med. 2000; 124: 14401447.
  • 5
    Mazzaferri EL, Jhiang SM. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med. 1994; 97: 418428.
  • 6
    Hundahl SA, Cady B, Cunningham MP, et al., for the U.S. and German Thyroid Cancer Study Group. Initial results from a prospective cohort study of 5583 cases of thyroid carcinoma treated in the United States during 1996. An American College of Surgeons Commission on Cancer Patient Care Evaluation Study. Cancer. 2000; 89: 202217.
  • 7
    Hölzer S, Reiners C, Mann K, et al., for the U.S. and German Thyroid Cancer Group. Patterns of care for patients with primary differentiated carcinoma of the thyroid gland treated in Germany during 1996. Cancer. 2000; 89: 192201.
  • 8
    Ruegemer JJ, Hay ID, Bergstralh EJ, Ryan JJ, Offord KP, Gorman CA. Distant metastases in differentiated thyroid carcinoma: a multivariate analysis of prognostic variables. J Clin Endocrinol Metab. 1988; 67: 501508.
  • 9
    Chow SM, Law SC, Au SK, et al. Differentiated thyroid carcinoma: comparison between papillary and follicular carcinoma in a single institute. Head Neck. 2002; 24: 670677.
  • 10
    Cerutti JM, Delcelo R, Amadei MJ, et al. A preoperative diagnostic test that distinguishes benign from malignant thyroid carcinoma based on gene expression. J Clin Invest. 2004; 113: 12341242.
  • 11
    Machens A, Holzhausen HJ, Lautenschläger C, Thanh PN, Dralle H. Enhancement of lymph node metastasis and distant metastasis of thyroid carcinoma. A multivariate analysis of clinical risk factors. Cancer. 2003; 98: 712719.
  • 12
    Machens A, Hinze R, Thomusch O, Dralle H. Pattern of nodal metastasis for primary and reoperative thyroid cancer. World J Surg. 2002; 26: 2228.
  • 13
    Röher HD, Simon D, Goretzki PE. Guidelines in oncologic surgery: malignant thyroid tumors. Langenbecks Arch Surg. 1997; (Suppl. II) 114: 142145.
  • 14
    Hinze R, Holzhausen HJ, Gimm O, Dralle H, Rath FW. Primary hereditary medullary thyroid carcinoma—C-cell morphology and correlation with preoperative calcitonin levels. Virchows Arch. 1998; 433: 203208.
  • 15
    World Health Organization. International histological classification of tumours. Geneva: World Health Organization. 2nd edition. Berlin: Springer, 1988.
  • 16
    Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958; 53: 457481.
  • 17
    HennekensCH, BuringJE, MayrentSL, editors. Epidemiology in medicine. Boston: Little, Brown and Company, 1987.
  • 18
    SobinLH, WittekindC, editors. TNM classification of malignant tumors. 6th edition. New York: John Wiley & Sons, 2002.
  • 19
    SobinLH, WittekindC, editors. TNM classification of malignant tumors. 5th edition. New York: John Wiley & Sons, 1997.
  • 20
    Singer PA, Cooper DS, Daniels GH, et al. Treatment guidelines for patients with thyroid nodules and well-differentiated thyroid cancer. Arch Intern Med. 1996; 156: 21652172.
  • 21
    Hegedüs L. The thyroid nodule. N Engl J Med. 2004; 351: 17641771.
  • 22
    Shimamoto K, Satake H, Sawaki A, Ishigaki T, Funahashi H, Imai T. Preoperative staging of thyroid papillary carcinoma with ultrasonography. Eur J Radiol. 1998; 29: 410.
  • 23
    Yeh MW, Demircan O, Ituarte P, Clark OH. False-negative fine-needle aspiration cytology results delay treatment and adversely affect outcome in patients with thyroid carcinoma. Thyroid. 2004; 14: 207215.